SARS-CoV-2

- Recently reported positive six-month immunogenicity data for IVX-121 against RSV; first clinical evidence of potential differentiation on durability with company’s VLP platform - - Phase 1 study of IVX-A12 (a bivalent of IVX-121 for RSV…

Hamsters infected with SARS-COV-2 and then treated with BiondVax’s inhaled anti-COVID-19 nanosized antibodies (NanoAbs) had over 30-times lower lung viral titer on average compared to those treated with inhaled placeboResult builds on…

…

LONDON: Scientists have discovered that a tailor-made pocket within the SARS-CoV-2 spike protein, which is capable of binding itself to the human cell surface, is what results in some coronaviruses causing severe…

JUPITER, Fla., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the…

By ANI WASHINGTON: According to research, a blood test conducted at the time of Covid-19 infection can help indicate whether a person is likely to develop long-term Covid. The study, published in the Lancet…

By PTI TOKYO: Researchers in Japan have developed a new antibody-based method for the rapid and reliable detection of SARS-CoV-2 that does not require a blood sample. The ineffective identification of…

Amid a monkeypox outbreak in several countries, researchers here have said that the possibility of the disease becoming a pandemic is low, and that the virus can be contained by strong surveillance, isolation of confirmed cases, contact…

Trained sniffer dogs can accurately detect airport passengers infected with SARS-CoV-2, the virus that causes COVID-19, according to a study published in the journal BMJ Global Health. This method of detection is likely to be valuable, not…

CARLSBAD, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Pardes Biosciences, Inc. (NASDAQ: PRDS), a clinical-stage biopharmaceutical company developing PBI-0451 as a potential stand-alone novel direct-acting, oral antiviral drug candidate for…